Products
-
- BBB DamageCell Death and ApoptosisNeuroinflammationNeuronal Damage and RepairOxidative StressVascular Mechanisms
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Human CRYGN Protein (AC1826)
Cat.#: ACPP-1826
Specifications
Despition CRYGN Human Recombinant SIZE 5 µg Purity > 90% (SDS-PAGE) Form Sterile Filtered colorless solution. Storage Store at 4°C for 2-4 weeks. Shipping Shipped at 4°C Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Size Price ACPP-1247 GSK3 beta Blocking Peptide (AC1247) 250 µg inquiry ACPP-1275 Usherin Blocking Peptide (AC1275) 250 µg inquiry ACPP-1168 KCNJ5 Blocking Peptide (AC1168) 250 µg inquiry ACPP-1139 Recombinant Human Cadherin 10 Protein (6×His Tag) (AC1139) 50 µg inquiry ACPP-1297 p75 NGF Receptor Blocking Peptide (AC1297) 250 µg inquiry ACPP-1681 Human CALN1 Protein (AC1681) 1 µg inquiry ACPP-1453 Human ACOT7 Protein (AC1453) 5 µg inquiry ACPP-1287 Dopamine Receptor D1 Blocking Peptide (AC1287) 250 µg inquiry ACPP-1480 Human FKBP1B Protein (AC1480) 5 µg inquiry ACPP-1332 GAD65 Blocking Peptide (AC1332) 250 µg inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
0Inquiry Basket